Chemoinformaics analysis of Kaempferol-3-xylosylglucoside
| Molecular Weight | 580.495 | nRot | 7 |
| Heavy Atom Molecular Weight | 552.271 | nRig | 29 |
| Exact Molecular Weight | 580.143 | nRing | 5 |
| Solubility: LogS | -3.796 | nHRing | 3 |
| Solubility: LogP | -0.794 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 69 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 2 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 17 |
| nHA | 15 | APOL | 74.1202 |
| nHD | 9 | BPOL | 37.6378 |
| QED | 0.15 |
| Synth | 4.566 |
| Natural Product Likeliness | 1.881 |
| NR-PPAR-gamma | 0.937 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.955 |
| HIA | 0.9 |
| CACO-2 | -6.305 |
| MDCK | 0.0000319 |
| BBB | 0.211 |
| PPB | 0.827534 |
| VDSS | 0.731 |
| FU | 0.236403 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.021 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.367 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.153 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.006 |
| CL | 1.284 |
| T12 | 0.464 |
| hERG | 0.037 |
| Ames | 0.767 |
| ROA | 0.062 |
| SkinSen | 0.027 |
| Carcinogencity | 0.145 |
| EI | 0.01 |
| Respiratory | 0.01 |
| NR-Aromatase | 0.95 |
| Antiviral | Yes |
| Prediction | 0.77138 |